imatinib mesylate has been researched along with Hyperoxia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bavis, RW; DeAngelis, KJ; Horowitz, TC; March, RJ; Reedich, LM | 1 |
| Auten, RL; Foster, WM; Mason, SN; Potts, EN; Schultz, ED | 1 |
| Andrade-Gordon, P; Friedlander, M; Kurokawa, T; Mueller, BM; Ruf, W; Uusitalo-Jarvinen, H | 1 |
3 other study(ies) available for imatinib mesylate and Hyperoxia
| Article | Year |
|---|---|
Hyperoxia-induced developmental plasticity of the hypoxic ventilatory response in neonatal rats: contributions of glutamate-dependent and PDGF-dependent mechanisms.
Topics: Analysis of Variance; Animals; Animals, Newborn; Benzamides; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutamic Acid; Hyperoxia; Hypoxia; Imatinib Mesylate; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Piperazines; Platelet-Derived Growth Factor; Pulmonary Ventilation; Pyrimidines; Rats; Rats, Sprague-Dawley | 2014 |
Mast cells mediate hyperoxia-induced airway hyper-reactivity in newborn rats.
Topics: Animals; Animals, Newborn; Anti-Asthmatic Agents; Benzamides; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Cromolyn Sodium; Female; Hyperoxia; Imatinib Mesylate; Lung; Mast Cells; Methacholine Chloride; Piperazines; Pregnancy; Protein Kinase Inhibitors; Pyrimidines; Random Allocation; Rats; Rats, Sprague-Dawley; Respiration | 2010 |
Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
Topics: Animals; Benzamides; Blood Coagulation Factor Inhibitors; Cell Line, Tumor; Disease Models, Animal; Factor VIIa; Hyperoxia; Hypoxia; Imatinib Mesylate; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neoplasms, Experimental; Neovascularization, Pathologic; Oxygen; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, PAR-1; Receptor, PAR-2; Retinal Neovascularization; Retinal Vessels; Signal Transduction; Thromboplastin; Time Factors | 2007 |